Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Status:
Completed

Trial end date:
2007-06-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of actinic keratoses.

Phase 2

Peplin